Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2.

Free radical biology & medicine - 1 Nov 2007

White Shai J, Kasman Laura M, Kelly Margaret M, Lu Ping, Spruill Laura, McDermott Paul J, Voelkel-Johnson Christina

Abstract excerpt

We have previously shown that doxorubicin sensitizes prostate cancer cells to tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Sensitization correlated with decreased expression of the antiapoptotic cellular FLICE-like inhibitor protein (cFLIP(S)). The decrease in cFLIP(S) could n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Deferoxamine
Share to Doxorubicin
Share to Drug Synergism

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Free Radicals

Share to Iron Chelating Agents

Share to Protein Synthesis Inhibitors

Share to TNF-Related Apoptosis-Inducing Ligand

Share to X-Linked Inhibitor of Apoptosis Protein

Source

Open in PubMed Open full text

Identifiers

PMID: 17893044
DOI: 10.1016/j.freeradbiomed.2007.06.015
PMCID: PMC2084083

Genes

XIAP

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-17893044-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Doxorubicin generates a proapoptotic phenotype by phosphorylation of elongation factor 2.PMID 17893044Read ↗

Doxorubicin-DNA Adducts Induce a Non-Topoisomerase II–Mediated Form of Cell DeathSemantic proximity Read ↗

The anti-cancer drug doxorubicin induces substantial epigenetic changes in cultured cardiomyocytesSemantic proximity Read ↗

Doxorubicin induces cardiomyocyte apoptosis and atrophy through cyclin-dependent kinase 2–mediated activation of forkhead box O1Semantic proximity Read ↗

BRCA2 protein deficiency exaggerates doxorubicin-induced cardiomyocyte apoptosis and cardiac failure.Semantic proximity Read ↗

Progressive suppression of DNA repair genes with persistent p53 activation in Doxorubicin-treated cardiomyocytesSemantic proximity Read ↗

Doxorubicin induces senescence or apoptosis in rat neonatal cardiomyocytes by regulating the expression levels of the telomere binding factors 1 and 2.Semantic proximity Read ↗

Mitochondrial ROS‐induced ERK1/2 activation and HSF2‐mediated AT1R upregulation are required for doxorubicin‐induced cardiotoxicitySemantic proximity Read ↗

Chemosensitization of Prostate Cancer by Modulating Bcl-2 Family ProteinsSemantic proximity Read ↗

The Mitochondrial Unfolded Protein Response (UPRmt), Regulated by ATF5, Attenuates Doxorubicin Induced Cardiotoxicity.Semantic proximity Read ↗

Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.Semantic proximity Read ↗

Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.Semantic proximity Read ↗

Change in TNF- <i>α</i> Receptor Expression Is a Relevant Event in Doxorubicin-Induced H9c2 Cardiomyocyte Cell DeathSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.